These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 10523942

  • 1. [Chronic heart insufficiency should be treated also with spironolactone].
    Kjeldsen KP, Nørgaard A, Thygesen K.
    Ugeskr Laeger; 1999 Sep 13; 161(37):5132. PubMed ID: 10523942
    [No Abstract] [Full Text] [Related]

  • 2. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep 10; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract] [Full Text] [Related]

  • 3. Spironolactone in left-sided heart failure: how does it fit in?
    Margo KL, Luttermoser G, Shaughnessy AF.
    Am Fam Physician; 2001 Oct 15; 64(8):1393-8. PubMed ID: 11681781
    [Abstract] [Full Text] [Related]

  • 4. New hope for heart failure.
    DeMaria A.
    Health News; 1999 Sep 10; 5(11):1-2. PubMed ID: 10513252
    [No Abstract] [Full Text] [Related]

  • 5. What's old is new again. Spironolactone and heart failure.
    Lock M, Chun R.
    Can Fam Physician; 1999 Nov 10; 45():2621-2. PubMed ID: 10587769
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Value of diuretics and aldosterone antagonists in the treatment of heart failure].
    Schwinger RH.
    Dtsch Med Wochenschr; 1999 Sep 24; 124 Suppl 2():S40-7. PubMed ID: 10535046
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study].
    Schwinger RH.
    Dtsch Med Wochenschr; 1999 Aug 27; 124(34-35):987-8. PubMed ID: 10488324
    [No Abstract] [Full Text] [Related]

  • 10. [Blocking of aldosterone receptors reduces the risk of events in patients with severe cardiac failure].
    Opasich C.
    Ital Heart J Suppl; 2000 Mar 27; 1(3):425-6. PubMed ID: 10815276
    [No Abstract] [Full Text] [Related]

  • 11. Spironolactone for heart failure: a worthy addition to therapy.
    Rittenhouse SK.
    Adv Nurse Pract; 2001 Jan 27; 9(1):34-6, 39. PubMed ID: 12416036
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
    Diercks GF, Overdiek JW, van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 2001 Feb 03; 145(5):204-8. PubMed ID: 11219145
    [Abstract] [Full Text] [Related]

  • 13. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction. II. Diuretics.
    Fortuna P, Reis I, Ascenção R, Carneiro AV.
    Rev Port Cardiol; 2008 Feb 03; 27(7-8):977-89. PubMed ID: 18959094
    [Abstract] [Full Text] [Related]

  • 14. Role of spironolactone in heart failure should be emphasised.
    Mapstone J, Houston B, Gogarty M.
    BMJ; 2000 Sep 16; 321(7262):706-7. PubMed ID: 11202944
    [No Abstract] [Full Text] [Related]

  • 15. Usefulness of spironolactone in a specialized heart failure clinic.
    Sligl W, McAlister FA, Ezekowitz J, Armstrong PW.
    Am J Cardiol; 2004 Aug 15; 94(4):443-7. PubMed ID: 15325926
    [Abstract] [Full Text] [Related]

  • 16. [The significance of aldosterone in chronic heart failure: the RALES study].
    Simko F, Bada V, Simková M, Simko J, Kovács L, Hulín I.
    Vnitr Lek; 2002 Aug 15; 48(8):767-72. PubMed ID: 12425209
    [Abstract] [Full Text] [Related]

  • 17. [Cost-benefit analysis of spironolactone use in the treatment of chronic heart failure].
    Alvarez JS, Vílchez FG.
    Rev Esp Cardiol; 2001 Feb 15; 54(2):175-80. PubMed ID: 11181306
    [Abstract] [Full Text] [Related]

  • 18. [New evidence for the usefulness of an old drug in the treatment of heart failure].
    Oseguera Moguel J.
    Rev Invest Clin; 2000 Feb 15; 52(1):14-6. PubMed ID: 10818804
    [No Abstract] [Full Text] [Related]

  • 19. Effect of spironolactone on C-reactive protein levels in patients with heart disease.
    Godfrey V, Farquharson CA, Macdonald JE, Yee KM, Struthers AD.
    Int J Cardiol; 2007 Apr 25; 117(2):282-4. PubMed ID: 16899309
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.